OS9 抗体 (AA 232-413) (HRP)
Quick Overview for OS9 抗体 (AA 232-413) (HRP) (ABIN7165902)
抗原
See all OS9 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 232-413
-
交叉反应
- 人
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Human Protein OS-9 protein (232-413AA)
-
亚型
- IgG
-
-
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 232-413) antibody
OS9 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 465-666) antibodyOS9 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 1-612) antibodyOS9 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (Internal Region) antibodyOS9 适用: 人, 小鼠 WB, ELISA, IHC, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 466-667) antibodyOS9 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 471-672) antibodyOS9 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 353-612) antibodyOS9 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9) (AA 300-400), (Isoform 1) antibodyOS9 适用: 人, 小鼠 WB, IHC, IP, ICC, IF, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
-
别名
- OS9
-
背景
-
Background: Lectin which functions in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). May bind terminally misfolded non-glycosylated proteins as well as improperly folded glycoproteins, retain them in the ER, and possibly transfer them to the ubiquitination machinery and promote their degradation. Possible targets include TRPV4.
Aliases: Amplified in osteosarcoma 9 antibody, amplified in osteosarcoma antibody, ERLEC2 antibody, OS-9 antibody, Os9 antibody, OS9_HUMAN antibody, Osteosarcoma amplified 9 endoplasmic reticulum lectin antibody, Protein OS-9 antibody
-
UniProt
- Q13438
-
途径
- Maintenance of Protein Location, SARS-CoV-2 Protein Interactome
抗原
-
